Details for New Drug Application (NDA): 075239
✉ Email this page to a colleague
The generic ingredient in LABETALOL HYDROCHLORIDE is labetalol hydrochloride. There are fourteen drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the labetalol hydrochloride profile page.
Summary for 075239
| Tradename: | LABETALOL HYDROCHLORIDE |
| Applicant: | Hospira |
| Ingredient: | labetalol hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 075239
| Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for 075239
Suppliers and Packaging for NDA: 075239
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LABETALOL HYDROCHLORIDE | labetalol hydrochloride | INJECTABLE;INJECTION | 075239 | ANDA | Hospira, Inc. | 0409-2339 | 0409-2339-34 | 10 CARTON in 1 PACKAGE (0409-2339-34) / 1 CARTRIDGE in 1 CARTON / 4 mL in 1 CARTRIDGE (0409-2339-24) |
| LABETALOL HYDROCHLORIDE | labetalol hydrochloride | INJECTABLE;INJECTION | 075239 | ANDA | Cardinal Health 107, LLC | 55154-4747 | 55154-4747-5 | 5 CARTRIDGE in 1 BAG (55154-4747-5) / 4 mL in 1 CARTRIDGE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 5MG/ML | ||||
| Approval Date: | Nov 29, 1999 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
